Nivolumab,Relatlimab
BMS
['melsm', 'nivo', 'nivo+rela']
good to hear voice our frustration wrt nivo+rela- more 1st lines are nice but we need 2nd lines in #melsm #asco2023
#Melanoma patient advocate, MD/PhD, in want of patient-centred research. Member of the first EU Cancer Mission Board. Views are totally my own.